ACTIVITY OF VARIOUS AMPHIPHILIC AGENTS IN REVERSING MULTIDRUG RESISTANCE OF L-1210 CELLS

被引:24
作者
POMMERENKE, EW
OSSWALD, H
HAHN, EW
VOLM, M
机构
[1] GERMAN CANC RES CTR,INST EXPTL PATHOL,NEUENHEIMER FELD 280,W-6900 HEIDELBERG 1,GERMANY
[2] GERMAN CANC RES CTR,INST TOXICOL & CHEMOTHERAPY,W-6900 HEIDELBERG 1,GERMANY
[3] GERMAN CANC RES CTR,INST RADIOL & PATHOPHYSIOL,W-6900 HEIDELBERG 1,GERMANY
关键词
multidrug-resistance; nucleoside incorporation assay; reversal;
D O I
10.1016/0304-3835(90)90060-B
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several compounds (bamipine, chlorphenoxamine, estracyt, hycanthone, quinidine, quinine, tamoxifen, trifluoperazine and verapamil) have a common basic structure with the following features: lipophilic aromatic ring system; linked chain hydrophilic N-alkyl group. They are used medically for varying diseases. Their activity in reversing multidrug-resistance (MDR) with other compounds (diethylstilbestrol, β-estradiol, methylbiguanide, methylpiperazine, testosterone) lacking one of these chemical features is compared. The in vitro test system we used was the nucleoside incorporation assay using parental L 1210 ascites tumor cells and a doxorubicin resistant subline, which expresses the MDR phenotype. The substances lacking one of these features were not effective in reversing the MDR whereas all other tested substances demonstrated modulating potential in the MDR resistant L 1210 cells. © 1990.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 27 条
[1]   THE CELL BIOLOGY OF MULTIPLE-DRUG RESISTANCE [J].
BECK, WT .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (18) :2879-2887
[2]   MECHANISM OF MULTIDRUG RESISTANCE [J].
BRADLEY, G ;
JURANKA, PF ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :87-128
[3]   INTERNAL DUPLICATION AND HOMOLOGY WITH BACTERIAL TRANSPORT PROTEINS IN THE MDR1 (P-GLYCOPROTEIN) GENE FROM MULTIDRUG-RESISTANT HUMAN-CELLS [J].
CHEN, CJ ;
CHIN, JE ;
UEDA, K ;
CLARK, DP ;
PASTAN, I ;
GOTTESMAN, MM ;
RONINSON, IB .
CELL, 1986, 47 (03) :381-389
[4]   DRUG-RESISTANCE IN MULTIPLE-MYELOMA AND NON-HODGKINS LYMPHOMA - DETECTION OF P-GLYCOPROTEIN AND POTENTIAL CIRCUMVENTION BY ADDITION OF VERAPAMIL TO CHEMOTHERAPY [J].
DALTON, WS ;
GROGAN, TM ;
MELTZER, PS ;
SCHEPER, RJ ;
DURIE, BGM ;
TAYLOR, CW ;
MILLER, TP ;
SALMON, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :415-424
[5]  
DAN K, 1973, BIOCHIM BIOPHYS ACTA, V323, P466
[6]  
GERLACH JH, 1986, CANCER SURV, V5, P23
[7]   SURFACE GLYCOPROTEIN MODULATING DRUG PERMEABILITY IN CHINESE-HAMSTER OVARY CELL MUTANTS [J].
JULIANO, RL ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 455 (01) :152-162
[8]   THE MULTIDRUG RESISTANCE PHENOTYPE [J].
KAYE, SB .
BRITISH JOURNAL OF CANCER, 1988, 58 (06) :691-694
[9]  
KESSEL D, 1986, CANCER SURV, V5, P109
[10]   CLINICAL MODULATION OF DOXORUBICIN RESISTANCE BY THE CALMODULIN-INHIBITOR, TRIFLUOPERAZINE - A PHASE-I/II TRIAL [J].
MILLER, RL ;
BUKOWSKI, RM ;
BUDD, GT ;
PURVIS, J ;
WEICK, JK ;
SHEPARD, K ;
MIDHA, KK ;
GANAPATHI, R .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :880-888